Insulet Achieves Key Milestones to Support its Transition to Direct Operations in Europe on July 1, 2018
Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that it has achieved key milestones as it transitions to direct operations in Europe on July 1st. The Company has established a highly-talented European commercial team with deep knowledge of the diabetes landscape and extensive experience within the local markets. In addition, Insulet has partnered with two well respected and experienced companies - Teleperformance and HealthLink Europe - which will provide the full breadth of Insulet’s customer care, product support, distribution and logistics services.
“We are excited about the significant progress we have made building an incredibly talented and knowledgeable team and strong partnerships to support our Omnipod users and healthcare professionals in Europe,” said Shacey Petrovic, President and Chief Operating Officer. “We are laser-focused on continuity of care and a seamless transition and I have full confidence this team will deliver best-in-class support for our European customers starting July 1st.”
Teleperformance is the worldwide leader in outsourced customer care management and will manage Insulet’s Customer Care services across Europe. HealthLink Europe is a highly experienced healthcare and medical device third-party logistics provider and will manage Insulet’s product distribution throughout Europe.
The latest updates about the transition in Europe are available at https://www.omnipodeurope.com.
About the Omnipod Insulin Management System:
The Omnipod Insulin Management System is an innovative continuous insulin delivery system that provides all the proven benefits of continuous subcutaneous insulin infusion (CSII) therapy in a way no conventional insulin pump can. The Omnipod System's innovative design and features allows people living with diabetes to live their life—and manage their diabetes—with unprecedented freedom, comfort, convenience, and ease. The Omnipod System consists of two components: (i) a Pod that stores and delivers insulin; and (ii) a Personal Diabetes Manager (PDM) that wirelessly programs the user's personalized insulin delivery, calculates suggested doses and insulin on board, and has a convenient, built-in blood glucose meter. The small, light-weight Pod can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back and, because it is waterproof (IPX8), there is no need to remove when showering, swimming or performing other activities. This means that Omnipod can provide up to three days of non-stop insulin delivery, without the need to disconnect a tube set or manually inject insulin. The Pod and PDM communicate wirelessly to offer precise, personalized and continuous insulin delivery with customizable basal and bolus delivery options, as well as important safety checks. The Pod's auto-cannula insertion is quick, simple, and virtually pain-free. Users never have to handle a needle. The user simply pushes a button on the PDM and the Pod's automated insertion system inserts the cannula beneath the skin and begins delivering insulin according to the user's programmed basal rate.
The Omnipod System is the world's first commercially available tubeless insulin delivery system that allows users to live untethered by tubing and without the stress and anxiety of multiple daily injections. By breaking down the barriers to insulin pump therapy, the Omnipod System offers freedom for users to live life on their own terms and with the ease of use they deserve.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com and https://www.omnipodeurope.com.*
*Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it already does in the United States and Canada.
This press release may contain forward-looking statements concerning Insulet's expectations, anticipations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on its current expectations and beliefs concerning future developments and their potential effects on Insulet. There can be no assurance that future developments affecting Insulet will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond its control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, and other risks and uncertainties described in its Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on February 22, 2018 in the section entitled "Risk Factors," and in its other filings from time to time with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of its assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Insulet undertakes no obligation to publicly update or revise any forward-looking statements.
Deborah R. Gordon, 978-600-7717
Vice President, Investor Relations and Corporate Communications
Dominic Hulton, +44 20 3941 5374
Vice President, Marketing, Europe
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Lion/Gem Luxembourg 3 S.a.r.l. Announce Second Quarter Results for FY 201824.5.2018 11:00 | Tiedote
The Second Quarter results for FY18 for Lion/Gem Luxembourg 3 S.a.r.l. (associated with Young’s Seafood Limited) will be made available on our Investor Relations website on May 24, 2018. The Second Quarter results call for investors that accompanies this information is scheduled to take place at 13:00 BST on May 24, 2018. The Second Quarter covers the quarter to 31 March 2018; the financial year end for Lion/Gem Luxembourg 3 S.a.r.l. is September 30, 2018. For further information: If you are an investor or a potential investor in the 8¼%/ 9% Senior PIK Notes due 2019, of Lion/Gem Luxembourg 3 S.a.r.l., and would like access to this information, please register your interest on our Investor Relations website: https://youngsseafood.co.uk/investors/. If you have any questions about the registration process or need further information, please do not hesitate to contact Nicholas Donnelly, Communications Manager at Young’s Seafood: firstname.lastname@example.org This announcement cont
Rakuten Announces Signing of Andrés Iniesta to Vissel Kobe24.5.2018 10:55 | Tiedote
Rakuten Vissel Kobe, Inc., a Rakuten Group company, today announced that Andrés Iniesta will join Vissel Kobe, the much-loved Western Japan football club, after an historic career at FC Barcelona, one of the most iconic and beloved football clubs in the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180524005463/en/ Since the beginning of his professional career with FC Barcelona in 2002, Iniesta has not only become one of the top players in the world, he is also renowned for his embodiment of the philosophy and values of the iconic club, with his commitment to teamwork and beautiful play. With a social media presence that includes over 74 million followers, Iniesta is also known as a global influencer. Iniesta developed his football career through the FC Barcelona cantera, the club’s unique youth league system that fosters young players, and his addition to Vissel Kobe is not only expected to draw in fans to see his
Poseidon Foundation Launches First Retail Platform That Allows Consumers to Support Climate Action Using Blockchain Technology24.5.2018 10:13 | Tiedote
The world’s first retail platform that connects consumers to their own carbon footprint has been launched in London by non-profit ogranisation the Poseidon Foundation (“Poseidon”). Poseidon’s platform uses blockchain technology to integrate carbon markets into transactions at the point-of-sale, giving retailers and their customers the opportunity to support forestry conservation projects around the world when they buy and sell everyday items, and in turn support action on climate change. The retail platform launched on 1st May, and a pilot is currently underway at Ben & Jerry’s newest ice cream Scoop Shop in Wardour Street, London. For every scoop of ice cream sold the values-led ice cream company is contributing towards carbon credits from a forest conservation project in Peru, and is offering their customers the opportunity to join them in taking action at the point of sale, using blockchain technology. Ben & Jerry’s has been vocal for many years on the issue of climate justice, incl
GSMA Announces New Events and Programmes Taking Place at Mobile World Congress Shanghai 201824.5.2018 10:00 | Tiedote
The GSMA today provided further details on the array of events and programmes that will be available to attendees at the 2018 GSMA Mobile World Congress Shanghai, including partner and co-located events; GSMA Forums, Seminars and Workshops; and Partner Programmes. Mobile World Congress Shanghai will be held 27-29 June at the Shanghai New International Expo Centre (SNIEC). “We’ve expanded the number of programmes and events at Mobile World Congress Shanghai, featuring everything from sports and fitness to service robots to the intersection of art and innovation, and beyond,” said Michael O’Hara, Chief Marketing Officer, GSMA. “We have a very exciting event lined up and we are looking forward to bringing the mobile world together in Shanghai next month.” New Details on Partner and Co-located Events at Mobile World Congress Shanghai The GSMA today provided an update on the partner and co-located events that will be held concurrently with Mobile World Congress Shanghai, offering attendees
FUELSAVE GmbH: FS MARINE+ is Revolutionizing Shipping Efficiency, Helping Ship Operators to Become Cleaner & More Profitable for a Unique Win-Win24.5.2018 10:00 | Tiedote
FUELSAVE GmbH is launching a revolutionary efficiency enhancement technology for Diesel (MGO / MDO) and Heavy-Fuel-Oil (HFO) engines on maritime vessels, which has been field & laboratory proven to significantly reduce fuel consumption and save contractually guaranteed 10% of the overall fuel costs, to lower the OPEX and increase profitability, while significantly reducing emissions ( CO2 by 10-15%, FSN by 40%, NOx by 30-70% etc.) for saving the environment and reducing Green House Gases (GHG) with a visible exhaust smoke reduction. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180524005120/en/ FS MARINE+ Next Generation Efficiency Enhancement for Maritime Vessels The company's breakthrough unit, called FS MARINE+ is an engine efficiency enhancement solution, with an onboard hydrogen syngas generator, which combines different processes of gas and liquid water methanol injection to significantly improve combustion efficiency
Elliott Advisors (UK) Limited Statement on thyssenkrupp AG24.5.2018 09:30 | Tiedote
Further to recent media speculation, funds advised by Elliott Advisors (UK) Limited (“Elliott”) confirm that they are significant shareholders in thyssenkrupp AG (“thyssenkrupp” or the “Company”). The funds’ position in ordinary shares is such that it does not exceed, as of today, the thresholds mandating disclosure under applicable German laws. Elliott will make any disclosure regarding its holdings in the shares of thyssenkrupp no later than when and as required by German law. Elliott’s approach to its investment in thyssenkrupp is consistent with its approach to all its investments. Elliott has spent significant time and resources analysing the Company, performing exhaustive research on its prospects, competitive positioning and valuation. Elliott believes thyssenkrupp has significant scope for operational improvement which would benefit all stakeholders and looks forward to engaging in a constructive dialogue with them in the near future, including with the supervisory and manageme
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme